Meet the Experts

Accomplished pharmaceutical executive with over two decades of experience spanning various leadership roles in global market access, pricing, commercial strategy, and marketing within the oncology, rare diseases, and other therapeutic areas. Demonstrated expertise in building and leading cross-functional teams to drive value-based access strategies, pricing initiatives, and evidence generation efforts across diverse markets including the US, EU, and emerging regions. Proven track record of success in launching and commercializing oncology products, optimizing market access, and fostering strategic partnerships. Holds an MBA in Marketing and a medical degree, combining clinical knowledge with business acumen to drive organizational growth and success.

Thought Leadership

Contract Commercial Services
- Article: Part 4: Navigating success during a rare disease product launch
  The video outlines best planning, timing, and budgeting practices in rare disease product launches. Watch here.
- Article: Navigating success during a rare disease product launch
  In this video, experts Kapil Raina, Chris Zealey, and Brian Williams, explore insights on successfully launching products in rare disease markets.
- Article: Part 3: Navigating success during a rare disease product launch
  The video outlines key success factors in rare disease markets through the five P's: People, Product, Payers, Promotion, and Placement. Watch here.
- Article: Part 2: Navigating success during a rare disease product launch
  Gain insights from Chief Commercial Officers on launching in the rare disease market. Watch here.
- Article: Part 1: Navigating success during a rare disease product launch
  Explore the rare disease landscape, focusing on patients' diagnostic and treatment challenges, competitive dynamics, and tailored launch strategies.
Launch Excellence
- Article: Part 4: Navigating success during a rare disease product launch
  The video outlines best planning, timing, and budgeting practices in rare disease product launches. Watch here.
- Article: Navigating success during a rare disease product launch
  In this video, experts Kapil Raina, Chris Zealey, and Brian Williams, explore insights on successfully launching products in rare disease markets.
- Article: Part 3: Navigating success during a rare disease product launch
  The video outlines key success factors in rare disease markets through the five P's: People, Product, Payers, Promotion, and Placement. Watch here.
- Article: Part 2: Navigating success during a rare disease product launch
  Gain insights from Chief Commercial Officers on launching in the rare disease market. Watch here.
- Article: Part 1: Navigating success during a rare disease product launch
  Explore the rare disease landscape, focusing on patients' diagnostic and treatment challenges, competitive dynamics, and tailored launch strategies.
Market Access
- Article: Part 4: Navigating success during a rare disease product launch
  The video outlines best planning, timing, and budgeting practices in rare disease product launches. Watch here.
- Article: Navigating success during a rare disease product launch
  In this video, experts Kapil Raina, Chris Zealey, and Brian Williams, explore insights on successfully launching products in rare disease markets.
- Article: Part 3: Navigating success during a rare disease product launch
  The video outlines key success factors in rare disease markets through the five P's: People, Product, Payers, Promotion, and Placement. Watch here.
- Article: Part 2: Navigating success during a rare disease product launch
  Gain insights from Chief Commercial Officers on launching in the rare disease market. Watch here.
- Article: Part 1: Navigating success during a rare disease product launch
  Explore the rare disease landscape, focusing on patients' diagnostic and treatment challenges, competitive dynamics, and tailored launch strategies.
- Article: Fed-Up Hospitals are Starting Their Own Drug Company to Lower Generic Drug Prices
  Read the article about the cost and supply challenges leading to Hospitals needing to start their own drug companies to lower generic drug prices.
- White Paper: Pre-approval Information Exchange Playbook
  Discover how to tailor product launches effectively with our Archetype Playbook. Master your market strategy now.
- Article: 5 Ways the Build Back Better Act Will Reduce Costs
  Explore 5 key strategies the Build Back Better Act employs to cut drug costs. Essential insights for pharma strategy. Click to learn more.